Skip to main content
Elsevier

Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B

  • 1st Edition, Volume 166 - July 30, 2025
  • Latest edition
  • Editors: Arun Kumar Singh, Kenneth Murphy, Neeraj Mishra, Frederick Alt, Sumel Ashique, Pranav Kumar Prabhakar
  • Language: English

Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immuno… Read more

Description

Advances in Immunology, Volume 166, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

Key features

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding and respected serial on the subject matter
  • Focuses on recent advances in the field of immunology

Readership

Immunologists and infectious disease specialists, cell biologists and hematologists

Table of contents

1. Harnessing the immune system: Insights into cancer vaccines

Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and

Chanakya Nath Kundu

2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy

Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal,

Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana

3. Nanoparticles for mRNA-based cancer immunotherapy

Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra

4. B-cell editing: An emerging alternative of precision oncotherapy

Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee,

Rathindranath Baral, and Anamika Bose

5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy

Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique,
and Mohhammad Ramzan

6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development

Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique,

Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin

7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy

Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain

Product details

  • Edition: 1
  • Latest edition
  • Volume: 166
  • Published: August 15, 2025
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran , India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.
Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab-140104, INDIA

KM

Kenneth Murphy

Kenneth M. Murphy works in Washington University School of Medecine, USA.
Affiliations and expertise
Washington University School of Medecine, USA

NM

Neeraj Mishra

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.

Affiliations and expertise
Professor and Head of Department, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Gwalior, Madhya Pradesh, India

FA

Frederick Alt

Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Affiliations and expertise
Professor of Pediatrics and Professor of Genetics, Harvard Medical School, Boston, MA, USA

SA

Sumel Ashique

Dr. Ashique is an academic in pharmaceutical sciences with experience in teaching and research, currently working as an Assistant Professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, India. His research and scholarly interests include drug delivery, nanotechnology, and targeted therapeutic strategies. He has authored and contributed to peer-reviewed publications and is also involved in book chapter contributions with established academic publishers. His work includes industry-oriented innovation reflected in granted patents from intellectual property and international jurisdictions.

PP

Pranav Kumar Prabhakar

Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

Affiliations and expertise
Professor and Head, Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India

View book on ScienceDirect

Read Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B on ScienceDirect